Multidisciplinary investigation of atypical inclusion complexes of beta-cyclodextrin and a phospholipase-A2 inhibitor

C E Dahlheim1, M M Dali, V H Naringrekar

  • 1Pharmaceutical Research Institute, Bristol-Myers Squibb, One Squibb Drive, P.O. Box 191, New Brunswick, New Jersey 08903-0191, USA. charles.dahlheim@bms.com

Related Concept Videos